Skip to main content
IMTX logo

Immatics N.V.

IMTXNASDAQHealthcareBiotechnology

$7.15Today:- (-)1Y −25.93%

As of Oct 26, 2026 close

Market cap
$977.26M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$6.65$12.41
Volume (live)
-
Avg. volume (3M)
959.26K

Immatics (IMTX) Income Statement

Immatics reported revenue of EUR 48.27M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 69.0% from EUR 155.84M a year earlier. Immatics posted a net loss of EUR 196.45M, compared with net income of EUR 15.22M a year earlier. Gross margin was 100.0% and operating margin -377.1%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was EUR 9.14M, up 93.0% from the same quarter a year earlier.

Immatics Income Statement Analysis

Values in millions EUR

Scroll to see more
Immatics N.V. income statement - Annual data in millions EUR
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue48.27155.8454.00172.8334.7631.2518.453.77
Cost of Revenue183.830.000.000.000.0067.0940.0933.97
Gross Profit48.27155.8454.00172.8334.76-35.83-21.64-30.20
Operating Expenses
Research & Development183.83148.08118.66106.7887.5767.0840.0933.97
Selling, General & Administrative51.1846.4538.2036.1233.8134.1911.767.67
Operating Expenses230.28194.45155.72142.88121.0633.8851.4638.18
Operating Income-182.02-38.62-101.7329.95-86.29-69.72-33.01-34.41
Other Income/Expense
Interest Income17.1825.0013.852.480.130.850.790.51
Interest Expense-0.950.890.831.040.57-0.290.170.02
Other Income/Expense-16.4259.964.7312.08-7.0419.870.532.05
Income
Income Before Tax-198.4421.35-96.9942.04-93.34-211.84-32.49-32.36
Income Tax Expense-1.996.13-2.3514.330.000.000.000.00
Net Income-196.4515.22-94.6527.70-93.34-211.28-31.74-31.44
Net Income - Continuous Operations-196.4515.22-94.6527.70-93.34-211.28-31.74-31.44
Net Income - Discontinued Operations--------
EBITDA-172.8834.46-88.9350.04-87.51-67.49-28.47-31.73
EBIT-182.0222.23-101.7343.07-92.77-69.72--
Depreciation & Amortization9.1412.237.236.975.262.233.852.25
Earnings Per Share
Basic EPS-2.00--1.001.00-1.00-4.00--
Diluted EPS-2.00--1.001.00-1.00-4.00--
Basic Shares Outstanding122.35106.8080.5566.9962.9148.0062.9162.91
Diluted Shares Outstanding122.35106.8080.5568.2162.9148.0062.9162.91

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Immatics Financial Statements

What was Immatics's revenue in fiscal 2025?

Immatics reported revenue of EUR 48.27M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 69.0% from EUR 155.84M a year earlier.

Is Immatics profitable?

No. Immatics reported a net loss of EUR 196.45M in fiscal 2025. In fiscal 2024 it earned EUR 15.22M.

What is Immatics's operating margin?

Immatics's operating income was −EUR 182.02M on revenue of EUR 48.27M in fiscal 2025, an operating margin of -377.1%, compared with -24.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition